Izumaotani T, Ishimura E, Tsmara K, et al. An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs. Nephron 1993;65:137.

Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapid progressive interstitial renal fibrosis in young women. Lancet 1993;341:387.

Depierreux M, Damme BV, Houte KV, et al. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994;24:172.

Cosyns JP, Jadoul M, Squifflet JP, et al. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 1994;45:1680.

Kabanda A, Jadoul M, Lauwerys R, et al. Low molecular weight proteinuria in Chinese herbs nephropathy. Kidney Int 1995; 48: 1571.

LEE CT, WU MS, LU K, et al. Renal tubular acidosis, hypokalemic paralysis, rhabdomyolysis, and acute renal failure — a rare presentation of Chinese herbs nephropathy. Renal Failure 1999;21:227.

YANG CS, LIN CH, CHANG SH, et al. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 2000;2:313–318.

Lord GM, Tagore R, Gower P, et al. Nephropathy caused by Chinese herbs in the UK. Lancet 1999;354(9177):481–482.

Vanherweghem JL. Misuse of herbal remedies. The case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J Altern Complement Med 1998;4:9–13.

Wankowicz Z, Obroniecha J, Morzycka-Michalik M. Nephropathy after use of Chinese herbs: rapid progressive interstitial renal fibrosis or renal vasculitis. Pol Arch Med Wewn 1996;96(5):474–478.

Yoshimura E, Fujii M, Koide S, et al. A case of Chinese herbs nephropathy in which the progression of renal dysfunction was slowed by steroid therapy. Nippon Jinzo Gakkai SHI 2000;42(2):66–72.

Tanaka A, Shinkai S, Kasuno K, et al. Chinese herbs nephropathy in the Kansai area: a warning report. Nippon Jinzo Gakkai SHI 1997;39(4):438–440.

Reginster F, Jadoul M, Struhou VY. Chinese herbs nephropathy presentation, natural history and fate after transplantation. Nephro Dial Transplant 1997;12(1):81–86.

Tanaka A, Shinkai S, Kasuno K, et al. Chinese herbs nephropathy in Japan presents adult-onset Fanconi syndrome: could different components aristolochic acids cause a different type of Chinese herbs nephropathy? Clin Nephrol 2000;53(4):301–306.

YIN G, HU WX, LI LS. Chinese herb nephropathy: experience of three cases of nephrotoxicity caused by Akebia quinata. J Nephrol Dialy Transplant 1998;8(1):10–14.

QIU Q, LIU ZH, YANG JW, et al. Experiment study of acute nephrotoxicity induced by Aristolochia manshuriensis Kom in rats. J Nephrol Dialy Transplant 1998;8(1):15–18.

Norden AG, Scheinman SJ, Descholdt-Lanchman MM, et al. Tubular proteinuria defined by a study of Dent’s (CLCN5 mutation) and other tubular diseases. Kidney Int 2000;57(1):240–249.

Nortier, Denscholdt-Lanchman, Simon. Proximal tubular injury in Chinese herbs nephropathy monitoring by neutral endopeptidase enzymuria. Kidney Int 1997;51:288–293.

John K. Nephropathy associated with the use of Aristolochia. Herbal Gram 2000;48:44–45.

HUANG KE, LI XB. Analysis of nephrotoxic Chinese herbs’ characters. New Chin Med Clin Pharmacol 1996;7(3):48–49.

GUO ZA. The Chinese herbs’ renal lesion. Chin J Integr Med 1998;18(1):54–56.

Tanaka A, Nishida R, Maeda K, et al. Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of Aristolochic acid cause a different type of Chinese herb nephropathy? Nephrol 2000;53(4):301–306.

Nouwen EJ, Zhu MQ, Savin M, et al. Introduce of apoptosis in the rat kidney by aristolochic acid. Abstract of 1995 ASN Annual Meeting; USA P1002.

Stuborova M, Frei E. Aristololactam I, a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy. Exp Toxicol Pathol 1999;51(4–5):421–427.

Nortier JL, Martinez MC, Schmeiser, et al. Urothelial carcinoma associated with the use of a Chinese herb. N Eng J Med 2000;342(23):1686–1692.

Cosyns JP, Jadoul M, Squifflet JP, et al. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 1999;33(6):1011–1017.

Megyesi J, Udvarrhely N, Safirstein RL, et al. The p53-independent activation of transcription of p21 WAF1/C1P1/sdl1 after acute renal failure. Am J Physiol 1996;271:1211–1216.

Godley JP, Kopp JB, Eckhaus M, et al. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev 1996;10(7):836–850.

Cosyns JP, Goebbels RM, Liberton V, et al. Organ toxicity and mechanisms: Chinese herb nephropathy-associated slimming regimen induces tumors in the forestomach but no interstitial nephropathy in rats. Arch Toxicol 1998;72:738–743.

WANG HY: Reinforce the study of the effect of tubular-interstitial lesion on the progression of glomerular diseases. Chin J Nephrol 2000;16(2):5–6.

Vanherweghem JL, Abramowicz D, Tielemens, et al. Effects of steroids on the progression of renal failure in chronic interstitial nephropathy in rats: a pilot study in Chinese herb nephropathy. Am J Kidney Dis 1996;27(2):209–215.

GAO RT, ZHENG FL, LIU YX, et al. Variation of intracellular free calcium concentration in aristolochic acid I induced apoptosis in LLC-PK1 cells and inhibition on apoptotic damage by Lacidine. J Nephrol Dialy Transplant 1998;8(1):6–9.

ZHANG WH. To compare the diuresis and poisonous effects of three kinds of Mutong. Chin J Pharmacol 1989:594–596.

CUI TG, WANG HY, SHANG MY, et al. Influence of caulis aristolochiae manchuriensis decoction on renal function and interstitial structure in rats at statuary dose according to pharmacopoeia. Chin J Nephrol 2000;16(2):106–109.